1 / 23

HIV and Tuberculosis interaction and integration

HIV and Tuberculosis interaction and integration. Anthony D Harries The “Union”, Paris, France London School of Hygiene & Tropical Medicine, UK.

trynt
Download Presentation

HIV and Tuberculosis interaction and integration

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. HIV and Tuberculosis interaction and integration Anthony D Harries The “Union”, Paris, France London School of Hygiene & Tropical Medicine, UK

  2. Epidemiology and Effects of HIV-TB Interaction

  3. Not HIV Infected Life time risk = 5-15% HIV Infected Annual risk = 5-15% Risk of TB in persons withMycobacterium tuberculosis

  4. Tuberculosis incidence rates (cases / 100 person-years) in HIV-infected patients prior to availability of antiretroviral therapy in South Africa and Italy Lawn et al, 2010: data adapted from Badri et al., 2002 and Antonucci et al., 1995

  5. HIV increases the number of young women with TB

  6. Estimated HIV-prevalence in patients with TB WHO Global Tuberculosis Control 2011

  7. Advancing HIV immune suppression [less inflammation and granuloma formation] PTB Smear-negative Infiltrations Lower lobe disease EPTB Disseminated disease PTB Smear-positive Cavities Upper lobe disease

  8. Mortality rates in HIV-infected smear-positive PTB patients before era of ART 1 Ackah et al, Lancet 1995; 345: 607-10; 2 Perriens et al, N Engl J Med 1995; 332: 779 – 84

  9. Lethal combination of HIV and DR-TB Gandhi et al, Am J Respir Crit Care Med 2010, 181: 80-6

  10. High rate of recurrent TB after successful treatment HIV+veHIV-ve Zaire 18% 6% (Perriens et al, 1991) Kenya 17% 0.5% (Hawken et al, 1993) Zambia 22% 6% (Elliott et al, 1995) S.Africa 16% 6% (Sonnenberg et al, 2001)

  11. Number of people receiving antiretroviral therapy in low- and middle-income countries, by region, 2002–2010

  12. Of HIV-infected patients who start antiretroviral therapy (ART) in Africa • 8% - 26% die in first year • Often due to diagnosed and undiagnosed TB Lawn SD et al. AIDS 2008; 22: 1897 - 1908

  13. TB Control derailed: More patients More difficult diagnosis Higher mortality Higher rate of recurrence HIV/AIDS care affected: Increased morbidity Increased mortality HIV effects on TB TB effects on HIV

  14. How to decrease the joint burden of HIV and TB?

  15. Milestone Clear guidance based on incomplete evidence Only 14 pages Multiple languages Adopted in > 160 countries and saved ~1 million lives in 8 years WHO Interim Policy: Jan 2004

  16. Between 2004 and 2012, new evidence for • TB prevention role of ART • Expanded use of HIV testing for patients with suspected TB, family members or contacts • Better integration of HIV-TB care

  17. 2012

  18. C. Reduce HIV burden in patients with TB Provider initiated HIV testing and counselling [PITC] If HIV- seropositive Start cotrimoxazole preventive therapy as soon as possible Start antiretroviral therapy as soon as possible

  19. B. Reduce TB burden in PLHIV Early antiretroviral therapy Infection control (TB) in high risk settings Intensified case finding for TB Active TB No active TB Anti-TB Treatment Isoniazid Preventive Therapy

  20. A. Integrated services: ART Clinic TB Clinic TBHIV and HIVTB Monitoring Number TB cases registered 340 Number TB cases HIV tested 275 Number TB cases HIV-positive 192 Number HIV+TB cases on CPT 186 Number HIV+TB cases on ART 122 Number of patients on ART 1025 No. screened for TB at last visit 825 No. diagnosed with TB 8 No. started on IPT 72 Co-location or integration of clinics

  21. Are we making progress? WHO Report 2011 Global Tuberculosis Control

  22. WE NEED TO DO BETTER: • Funding:we have to meet the funding gap • Knowledge: we need to continue doing the relevant science • Implementation:we need to do what works and be accountable

More Related